Skip to main content
Stryker Corporation
Healthcare · Medical Devices
Made on Aug 7, 2026
Price at call $337.43
6-month call Bear -6.4%
Target by Feb 2027 $316.00
Great value below $235.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change -6.4% to $316.00
Predicted High $338.50 in 2 weeks
Predicted Low $316.00 at 6 months
Max Drawdown (predicted) -6.4%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 7, 2026 1:11 am
Bear SYK trends lower to $316.00 (-6.4% from $337.43) by Feb 2027. decay
ThesisSYK trades well above composite fair value ($196) with a strongly negative value signal, but quality is solid and sentiment/regime are constructive with no near-term earnings catalyst. Path drifts modestly lower as valuation gravity slowly asserts itself, with mild near-term stability from risk-on tape.
Invalidated ifA break above $355 on strong volume or a broad market regime shift to risk-off accelerating the decline below $310 early
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $337.43 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 7, 2026 $337.43 at call The anchor — every point below is measured from this price and date.
2 weeks Aug 21, 2026 $311.30–$363.56 typical range · internal point $338.50 ±7.7% 6/10 Risk-on tape and no catalyst keep price steady
What actually happened: closed $327.70 on Aug 20, 2026 = -2.9% vs the call (predicted +0.3%)  ·  direction HIT (called flat, was flat)  ·  off by 3.2 pp  ·  accuracy 9/10  ·  typical range ±7.7%: inside the band  ·  S&P -1.5% over the same window — lagged it
1 month Sep 7, 2026 $299.57–$375.29 typical range · internal point $335.00 ±11.2% 6/10 Mild drift as momentum fades without catalyst
2 months Oct 7, 2026 $330.00 -2.2% 5/10 Q3 print approaches, valuation concerns re-emerge
3 months Nov 7, 2026 $326.00 -3.4% 5/10 Earnings likely fine but rich multiple caps upside
4 months Dec 7, 2026 $322.00 -4.6% 4/10 Year-end rebalancing trims extended quality names
5 months Jan 7, 2027 $319.00 -5.5% 4/10 Value gravity continues pulling toward deserved value
6 months Feb 7, 2027 $316.00 -6.4% 4/10 Converges near deterministic baseline endpoint

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $316.91 (-6.1%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$337.43
Composite fair value$195.98
Signal-adjusted fair value$179.29
DCF fair value$212.10
Anchored-PE fair value$250.74
Buy-below (value lens)$235.00
Value net score-79
Value confidence7 / 10
Quality net score+64
Memo confidence8 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 47.4%  3m 38.9%  6m 33.3%  
Daily σ (realism noise)2.4%
Beta vs S&P 500 1m -0.63  3m -0.45  5m 0.06  
Trailing 6-month return-6.4%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Aug 7, 2026 freshest SYK-20260807-000819-ce86
ext-forensic-memo Aug 7, 2026 freshest ext-SYK-20260807-005507-fd36
ext-lens-quality Aug 7, 2026 freshest ext-SYK-20260807-005507-fd36
ext-lens-sentiment Aug 7, 2026 freshest ext-SYK-20260807-005507-fd36
ext-lens-value Aug 7, 2026 freshest ext-SYK-20260807-005507-fd36
scenario-valuation Aug 7, 2026 freshest SYK-20260807-000819-ce86
valuation-synthesis Aug 7, 2026 freshest SYK-20260807-000819-ce86

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

1 frozen snapshot — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 7, 2026 v0.6.0 Bear $337.43 $316.00 -6.4% Feb 2027 viewing

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.